BasaraL.R.MontagneM. in press Drug Discovery and the American Consumer. Binghamton, New York: Pharmaceutical Products Press.
2.
HargravesR. (ed.) 1976The promotion of prescription and proprietary drugs: Corporate self-interest versus social responsibility. J. Drug Issues6(1): 1–104.
3.
KesslerD.A.1991Drug promotion and scientific exchange - The role of the scientific investigator. New England J. Med.325:201.
4.
KesslerD.A.PinesW.L.1990The federal regulation of prescription drug advertising and promotion. J. Amer. Med. Assoc.264:2409–15.
5.
MillsteinL.G.1988Advertising and promotion of prescription drug products. In Encyclopedia of Pharmaceutical Technology, SwarbrickJ.BoylanJ.C. (eds.) vol. 1: 147–87. New York: Marcel Dekker.
6.
MontagneM. (ed.) 1988Philosophies of drug giving and drug taking. J. Drug Issues18:139–284.
7.
MontagneM.1989Social exchange, values, and the marketing of pharmaceuticals. J. Pharmaceutical Marketing & Management3(3):45–55.
8.
MontagneM.BleidtB.A.1987Social forces in the premature removal of drug products from the marketplace. Clinical Research Practices & Drug Regulatory Affairs5:83–127.
9.
PriceT. (ed.) 1974Drug advertising hearings. J. Drug Issues4:203–312.
10.
RaischD.W.1990A model of methods for influencing prescribing: Part II. A review of educational methods, theories of human inference, and delineation of the model. DICP Annals of Pharmacotherapy24:537–42.
11.
SmithM.C.1991Pharmaceutical Marketing: Strategy and Cases. Binghamton, New York: Pharmaceutical Products Press.
12.
StarkD.C.1983The process of drug development: III. The evolution of pharmaceutical product marketing. Clinical Research Practices & Drug Regulatory Affairs1:263–90.
13.
U.S. Congress. Senate. Committee on Labor and Human Resources1991Advertising, Marketing, and Promotional Practices of the Pharmaceutical Industry, 1990.
14.
U.S. Congress. Senate. Subcommittee on Health1974Examination of the Pharmaceutical Industry, 1973–74. Parts 1–7.
15.
WellsH.G.1908Tono-Bungay. New York: Dodd, Mead and Co.